GFM
DFTX

GF Fund Management’s Definium Therapeutics DFTX Stock Holding History

GF Fund Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.8K Buy
2,213
+278
+14% +$4.72K ﹤0.01% 418
2025
Q4 		$25.9K Buy
1,935
+298
+18% +$3.69K ﹤0.01% 479
2025
Q3 		$19.3K Sell
1,637
-240
-13% -$2.24K ﹤0.01% 492
2025
Q2 		$12.2K Hold
1,877
– – ﹤0.01% 544
2025
Q1 		$11K Buy
1,877
+337
+22% +$2.41K ﹤0.01% 555
2024
Q4 		$10.7K Buy
+1,540
New +$10.6K ﹤0.01% 534

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GF Fund Management's DFTX Position: Q1 2026 in Review

GF Fund Management increased its Definium Therapeutics (DFTX) stake by 14% in Q1 2026, buying an estimated $4.72K and bringing the position to 2,213 shares worth $41.8K. The position accounts for ﹤0.01% of the portfolio, ranked #418.

GF Fund Management first reported a position in DFTX in Q4 2024 and has held it in 6 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • GF Fund Management held 2,213 shares of Definium Therapeutics worth $41.8K as of Q1 2026.
  • GF Fund Management bought 278 Definium Therapeutics shares in Q1 2026, an estimated $4.72K.
  • Definium Therapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #418 holding.
  • GF Fund Management first reported a position in Definium Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.